| Tretinoin | Approved Investigational Nutraceutical | USP53 | 54532 |
upregulated | Tretinoin results in increased expression of USP53 mRNA | 4q26 | |
| Tretinoin | Approved Investigational Nutraceutical | USP9X | 8239 |
downregulated | Tretinoin results in decreased expression of USP9X mRNA | Xp11.4 | |
| Tretinoin | Approved Investigational Nutraceutical | USP9X | 8239 |
upregulated | Tretinoin results in increased expression of USP9X mRNA | Xp11.4 | |
| Tretinoin | Approved Investigational Nutraceutical | UTF1 | 8433 |
downregulated | Tretinoin results in decreased expression of UTF1 mRNA | 10q26.3 | |
| Tretinoin | Approved Investigational Nutraceutical | UTP20 | 27340 |
downregulated | Tretinoin results in decreased expression of UTP20 mRNA | 12q23.2 | |
| Tretinoin | Approved Investigational Nutraceutical | UTRN | 7402 |
downregulated | Tretinoin results in decreased expression of UTRN mRNA | 6q24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | UVRAG | 7405 |
downregulated | Tretinoin metabolite results in decreased expression of UVRAG mRNA | 11q13.5 | |
| Tretinoin | Approved Investigational Nutraceutical | UVRAG | 7405 |
downregulated | Tretinoin results in decreased expression of UVRAG mRNA | 11q13.5 | |
| Tretinoin | Approved Investigational Nutraceutical | VAMP8 | 8673 |
upregulated | Tretinoin results in increased expression of VAMP8 mRNA | 2p11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | VASN | 114990 |
upregulated | Tretinoin results in increased expression of VASN mRNA | 16p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | VASP | 7408 |
upregulated | Tretinoin results in increased expression of VASP mRNA | 19q13.32 | |
| Tretinoin | Approved Investigational Nutraceutical | VAT1 | 10493 |
upregulated | Tretinoin results in increased expression of VAT1 mRNA | 17q21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | VAT1L | 57687 |
downregulated | Tretinoin results in decreased expression of VAT1L mRNA | 16q23.1 | |
| Tretinoin | Approved Investigational Nutraceutical | VAV1 | 7409 |
upregulated | Tretinoin results in increased expression of VAV1 mRNA | 19p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | VAV3 | 10451 |
upregulated | Tretinoin results in increased expression of VAV3 mRNA | 1p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | VCAN | 1462 |
upregulated | Tretinoin results in increased expression of VCAN mRNA | 5q14.2-q14.3 | |
| Tretinoin | Approved Investigational Nutraceutical | VDAC1P3 | 100310838 |
downregulated | Tretinoin results in decreased expression of VDAC1P3 mRNA | Xq21.31 | |
| Tretinoin | Approved Investigational Nutraceutical | VEGFA | 7422 |
downregulated | Tretinoin results in decreased expression of VEGFA mRNA | 6p21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | VEGFA | 7422 |
upregulated | Tretinoin results in increased expression of VEGFA mRNA | 6p21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | VEGFC | 7424 |
upregulated | Tretinoin metabolite results in increased expression of VEGFC mRNA | 4q34.3 | |
| Tretinoin | Approved Investigational Nutraceutical | VEGFC | 7424 |
downregulated | Tretinoin results in decreased expression of VEGFC mRNA | 4q34.3 | |
| Tretinoin | Approved Investigational Nutraceutical | VEZF1 | 7716 |
upregulated | Tretinoin results in increased expression of VEZF1 mRNA | 17q22 | |
| Tretinoin | Approved Investigational Nutraceutical | VGF | 7425 |
upregulated | Tretinoin results in increased expression of VGF mRNA | 7q22.1 | |
| Tretinoin | Approved Investigational Nutraceutical | VGLL3 | 389136 |
downregulated | Tretinoin results in decreased expression of VGLL3 mRNA | 3p12.1 | |
| Tretinoin | Approved Investigational Nutraceutical | VIM | 7431 |
downregulated | Tretinoin results in decreased expression of VIM mRNA | 10p13 | |